Abivax SA American Depositary Shares (ABVX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Abivax SA American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$89.84
+3.26% today
Market cap
$7.6B
Overall quality
24/100
Kronos AI 30-day
+27.0%
8 of 8 simulated paths end higher
Abivax SA American Depositary Shares (ABVX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7.6B. It trades at $89.84, up 3.26% today. Its overall quality score is 24 out of 100, ranked against the whole US market. 9 analysts' average target of $160.56 implies +78.7% from today's price. Kronos AI's 30-day forecast is +27.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $160.56 |
| Low – high | $118.00 – $180.00 |
| Analysts | 9 |
| Upside to average | +78.7% |
Kronos AI 30-day forecast
| Expected close | $110.49 (+27.0%) |
| Likely range | +23.7% … +32.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 2 |
| Solvency | 53 |
| Growth | 16 |
| Overall | 24 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.